|1.||Kashirtseva, I A: 1 article (01/2012)|
|2.||Mukhomedzianova, L V: 1 article (01/2012)|
|3.||Andriianova, I V: 1 article (01/2012)|
|4.||Garashchenko, T I: 1 article (01/2011)|
|5.||Zelenkova, I V: 1 article (01/2011)|
|6.||Alferova, M V: 1 article (01/2011)|
|7.||Vavilova, V P: 1 article (01/2003)|
|8.||Luchikhin, N A: 1 article (01/2002)|
|9.||Bogdanets, S A: 1 article (01/2002)|
|10.||Tettsoeva, Z M: 1 article (01/2002)|
01/01/2001 - "28 adult patients of both sexes with chronic bronchitis participated in an open study of intranasal treatment with IRS-19. "
01/01/1997 - "Twenty eight adult patients of both sexes with chronic bronchitis participated in an open study to determine the effect of intranasal treatment with IRS-19, an immunomodulating agent, on the number of polymorphonuclear leukocytes (PMNL), H2O2 concentration and myeloperoxidase (MPO) activity in nasal washings. "
01/01/1988 - "80 patients with chronic bronchitis were treated inhalatively for a time of 3 weeks with a polyvalent bacterial lysate (IRS 19) or with placebo. "
01/01/2001 - "[Effects of bacterial extract IRS-19 on the concentration of hydrogen peroxide and myeloperoxidase activity in nasal washings of patients with chronic bronchitis]."
01/01/1997 - "Effect of bacterial extract, IRS-19, on the concentration of hydrogen peroxide and myeloperoxidase activity in nasal washings of patients with chronic bronchitis."
|3.||Respiratory Tract Infections (Respiratory Tract Infection)
01/01/2012 - "It was shown that therapy with IRS-19 resulted in a more than two-fold reduction in the frequency of relapses of the acute respiratory infections as compared with control."
01/01/2012 - "[Experience with the use of IRS-19 for the rehabilitation of children after acute respiratory infections]."
01/01/1995 - "The assessment of the therapeutic effectiveness of IRS-19 in allergic children with recurrent or chronic respiratory infections."
01/01/2000 - "[Prevention and treatment of upper respiratory tract infections with IRS-19 and polydex with phenylephrine]."
01/01/2003 - "Children having frequent acute respiratory infections and chronic adenoiditis were given immunomodulators (ridostin, IRS-19, polyoxidonium). "
01/01/1995 - "The obtained therapeutic effects and convenience of administration of the vaccine, justify IRS-19 treatment in children with recurrent lower and upper airway infections, after complex immunological examination."
11/01/1992 - "IRS 19 eliminates relapses of infections of the upper respiratory pathways sooner."
|2.||Hydrogen Peroxide (Hydroperoxide)
|4.||Immunologic Factors (Immunomodulators)